Immunogenic cell variants of a mouse teratocarcinoma confer a protection against the original non-immunogenic transplantable tumor
- 1 October 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (10), 1083-1087
- https://doi.org/10.1016/0014-2964(81)90292-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.The Journal of Experimental Medicine, 1980
- Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.Proceedings of the National Academy of Sciences, 1977
- Induction of immune responsiveness in a genetically low‐responsive tumor‐host combination by chemical modification of the immunogenEuropean Journal of Immunology, 1976
- A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous originBritish Journal of Cancer, 1976
- Evidence for a Tumour-associated Antigen in Human Malignant MelanomaNature, 1973
- Cell‐mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in Murine sarcoma virus (MSV)‐induced tumors and transplanted lymphomasInternational Journal of Cancer, 1972
- The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryosDevelopmental Biology, 1970
- VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUSThe Journal of Experimental Medicine, 1967
- Antigenic Properties of Lymphomas Induced by the Moloney Agent2JNCI Journal of the National Cancer Institute, 1964
- Immunity to Methylcholanthrene-Induced SarcomasJNCI Journal of the National Cancer Institute, 1957